Installed Building Products Q4 FY25 earnings call IBP

Installed Building Products concluded 2025 with record sales and profitability, demonstrating resilience despite headwinds in core residential end markets. Consolidated sales increased 1% for the full year, while same-branch sales declined 1%. The company's focus on meeting customer needs, profitability, and product diversification, particularly in commercial end markets, contributed to this strong performance. Adjusted return on invested capital for 2025 was 24%, consistent with prior years.

The commercial end market was a significant driver of growth in 2025, with sales in the Installation segment up 10% on a same-branch basis for the full year. Heavy commercial sales were particularly strong, growing 38% on a same-branch basis in Q4 2025, and are expected to remain healthy in 2026 due to growing contract backlogs. This robust commercial performance largely offset weakness in the light commercial and new residential segments, contributing positively to overall profitability.

The new residential Insulation segment faced challenges in 2025, with residential same-branch sales down 4% for the full year, impacted by decreased single-family and multifamily sales. While the spring selling season is underway, management notes it's too early to draw conclusions. Single-family starts decreased 7% in 2025, while multifamily starts increased 18%. The company anticipates that readily available labor and materials could accelerate construction activity once demand inflects, particularly for entry-level production builders.

IBP remains committed to its growth-oriented capital allocation strategy, completing 11 acquisitions in 2025, adding over $64 million in annual revenue. This included four acquisitions in Q4 2025 and three more in early 2026, diversifying product offerings across residential and commercial markets. The company expects to acquire at least $100 million of annual revenue in 2026. Management expressed interest in expanding into commercial roofing and mechanical/industrial insulation, while continuing to pursue opportunities in the highly fragmented core residential insulation market.

The company generated $371 million in operating cash flow in 2025, a 9% year-over-year increase. Following a private offering of $500 million in senior unsecured notes and an amendment to its revolving credit facility, IBP boasts nearly $900 million in available liquidity and a net debt to TTM adjusted EBITDA leverage ratio of 1.1x, well below its 2x target. This strong financial position supports continued strategic acquisitions and shareholder returns, including a new $500 million stock buyback program and increased quarterly and variable dividends.

Adjusted gross margin reached a record 35% in Q4 2025, up from 33.6% in the prior year, primarily driven by a favorable shift in customer mix towards higher-margin private, semi-custom, and custom builders, as well as successful management of direct operating costs. The strong performance of the heavy commercial business also contributed approximately 40 basis points to gross margin improvement. While price/cost pressure is noted in the entry-level production builder segment, the company emphasizes its ability to effectively manage these dynamics.

Multifamily cycle times have normalized to pre-COVID levels, with 2025 starts up 18% and units under construction down 13%, suggesting the market is reaching equilibrium. This bodes well for full year 2026, especially with easier comps. Single-family cycle times are also at their most efficient, meaning any inflection in the entry-level production builder market would translate very quickly into installation demand for IBP, unlike the longer bid-to-install times in multifamily.